Balatian, Roseminda S.
HRN: 23-51-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/08/2023
08/14/2023
IV
1.5gm
Q6
Pyelonephritis
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes